The following is a short YouTube vlog on Rituximab, COVID-19 and vaccine readiness. This is a brief update to my presentation on anti-CD20 therapies and COVID-19 to iWiMS webinar on the 20-May-2020.
What is your opinion on vlogging vs. blogging? Is there a need for both?
CoI: multiple
I view the field of MS as being ‘Before Natalizumab or BN’ and ‘After Natalizumab or AN’ this vlog provides another important insight we have obtained from the reanalysis of the data from the original phase 3 or AFFIRM study.
CoI: multiple
I am trying something new instead of blogging, i.e. a podcast and a vlog. This week I cover some initial thoughts on how COVID-19 has affected MS Services and potentially MS research.
CoI: multiple
